Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Myriad Genetics (MYGN) Shares Outstanding (Diluted Average) (2017 - 2025)

Historic Shares Outstanding (Diluted Average) for Myriad Genetics (MYGN) over the last 13 years, with Q3 2025 value amounting to $93.1 million.

  • Myriad Genetics' Shares Outstanding (Diluted Average) rose 242.02% to $93.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $93.1 million, marking a year-over-year increase of 242.02%. This contributed to the annual value of $90.6 million for FY2024, which is 942.03% up from last year.
  • Per Myriad Genetics' latest filing, its Shares Outstanding (Diluted Average) stood at $93.1 million for Q3 2025, which was up 242.02% from $92.5 million recorded in Q2 2025.
  • Myriad Genetics' 5-year Shares Outstanding (Diluted Average) high stood at $93.1 million for Q3 2025, and its period low was $76.0 million during Q1 2021.
  • For the 5-year period, Myriad Genetics' Shares Outstanding (Diluted Average) averaged around $84.3 million, with its median value being $81.7 million (2023).
  • Its Shares Outstanding (Diluted Average) has fluctuated over the past 5 years, first crashed by 98.16% in 2022, then surged by 1098.9% in 2024.
  • Quarter analysis of 5 years shows Myriad Genetics' Shares Outstanding (Diluted Average) stood at $78.0 million in 2021, then grew by 3.33% to $80.6 million in 2022, then grew by 2.73% to $82.8 million in 2023, then rose by 9.42% to $90.6 million in 2024, then grew by 2.76% to $93.1 million in 2025.
  • Its Shares Outstanding (Diluted Average) stands at $93.1 million for Q3 2025, versus $92.5 million for Q2 2025 and $91.4 million for Q1 2025.